IndraLab

Statements

Trabectedin inhibits NFKB1. 1 / 1

| 1

reach

"Furthermore, trabectedin treatment inhibits in vitro NFkB pathway in mixoyd liposarcoma sensitive but not in resistant counterparts, and the inhibition of NFkB pathway re-sensitizes the resistant cells to trabectedin treatment."

29980789

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Trabectedin inhibits NFKB1. 1 / 1

INDRA sources:

Databases

Reading